Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C

TA106 Hepatitis C - peginterferon alfa and ribavirin: review decision - December 2013 information  

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive ^{PDF 111.64 KB} 20 December 2013  

TA106 Hepatitis C - peginterferon alfa and ribavirin: review proposal - October 2013 information  

TA106 Hepatitis C - peginterferon alfa and ribavirin: - Appendix A - provisional matrix of stakeholders ^{PDF 100.31 KB} 14 October 2013  

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix B - GE Proposal Paper September 2013 ^{PDF 534.1 KB} 14 October 2013  

Review decision, August 2008 information  

Review decision - March 2008: table of comments ^{PDF 135.33 KB} 13 August 2008  

Review proposal, March 2008 information  

Thousands more people with hepatitis C to benefit from latest NICE guidance on drug treatments information  

Thousands more people with hepatitis C to benefit from latest NICE guidance on drug treatments ^{PDF 42.03 KB} 23 August 2006  

Hepatitis C (mild) - interferon alfa (pegylated and non-pegylated) and ribavirin (review): Final appraisal determination information  

Hepatitis C (mild) - interferon alfa (pegylated and non-pegylated) and ribavirin (review): Final appraisal determination ^{PDF 105.07 KB} 12 May 2006  

Response to consultee and commentator comments on the ACD ^{PDF 89.68 KB} 12 May 2006  

Consultee and commentator comments on the ACD  

Association of Nurses in Substance Abuse ^{PDF 26.33 KB} 12 May 2006  

British Society of Gastroenterology ^{PDF 18.98 KB} 12 May 2006  

Department of Health Development Agency ^{PDF 43.95 KB} 12 May 2006  

Foundation of Liver Research ^{PDF 31.01 KB} 10 May 2006  

Haemophilia Society ^{PDF 41.96 KB} 12 May 2006  

Hepatitis C Trust ^{PDF 31.92 KB} 12 May 2006  

MRC Clinical Trials Unit ^{PDF 22.24 KB} 12 May 2006  

NHS Quality Improvement Scotland ^{PDF 26.07 KB} 10 May 2006  

Roche Products Limited ^{PDF 43.94 KB} 12 May 2006  

Royal College of General Practitioners ^{PDF 58.06 KB} 12 May 2006  

Royal College of Nursing ^{PDF 14.22 KB} 10 May 2006  

Royal College of Pathologists ^{PDF 52.17 KB} 12 May 2006  

Schering-Plough Ltd ^{PDF 37.44 KB} 10 May 2006  

Welsh Assembly Government ^{PDF 42.28 KB} 12 May 2006  

Welsh Assembly Government attachment ^{PDF 13.73 KB} 10 May 2006  

Foster ^{PDF 74.59 KB} 10 May 2006  

Hepatitis C (mild) - interferon alfa (pegylated and non-pegylated) and ribavirin (review): Appraisal consultation document information  

Final scope ^{PDF 34.78 KB} 24 March 2005  

Evaluation Report  

Hepatitis C - peginterferon alfa and ribavirin: assessment report ^{PDF 1.21 MB} 17 February 2006  

Overview ^{PDF 75.26 KB} 17 February 2006  

Consultee and commentator comments on the assessment report  

Royal College of Pathologists (2) ^{PDF 39.98 KB} 17 February 2006  

Schering Plough Ltd ^{PDF 41.56 KB} 17 February 2006  

CPAP ACD - Consultee and commentator comments: Royal College of Nursing ^{PDF 11.85 KB} 17 February 2006  

Roche Products Ltd ^{PDF 25.39 KB} 17 February 2006  

NHS Quality Improvement Scotland ^{PDF 15.88 KB} 17 February 2006  

MRC Clinical Trials Unit ^{PDF 30.24 KB} 17 February 2006  

Mainliners ^{PDF 32.15 KB} 17 February 2006  

Haemophilia Alliance and UK Haemophilia Centre ^{PDF 13.46 KB} 17 February 2006  

British Society of Gastroenterology ^{PDF 36.17 KB} 17 February 2006  

British Association for the Study of the Liver ^{PDF 13.21 KB} 17 February 2006  

Manufacturer submissions (executive summary only)  

Schering-Plough Ltd (2) ^{PDF 19.16 KB} 17 February 2006  

Roche Products Ltd (2) ^{PDF 41.82 KB} 17 February 2006  

Non manufacturer submissions  

Royal College of Pathologists ^{PDF 39.98 KB} 17 February 2006  

Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin: Appraisal consultation - Royal College of Physicians ^{PDF 21.66 KB} 17 February 2006  

Royal College of Nursing (2) ^{PDF 12.9 KB} 17 February 2006  

Hepatitis C Trust ^{PDF 44.73 KB} 17 February 2006  

Haemophilia Society ^{PDF 41.47 KB} 17 February 2006  

Expert written personal statements  

Morris ^{PDF 43.13 KB} 17 February 2006  

Maulayah ^{PDF 26.11 KB} 17 February 2006  

Gore ^{PDF 24.41 KB} 17 February 2006  

Foster ^{PDF 19.61 KB} 17 February 2006  

Final Protocol ^{PDF 75.14 KB} 24 March 2005  

Response to consultee and commentator comments on the draft scope ^{PDF 40.64 KB} 16 January 2005  

Response to consultee and commentator comments on the provisional matrix of consultees and commentators ^{PDF 21.97 KB} 16 January 2005  

Archive Draft scope ^{PDF 33.48 KB} 13 January 2005  

Archive Provisional matrix of consultees and commentators ^{PDF 29.51 KB} 13 January 2005